Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial

Laina D Mercer, Arlene C Seña, E Ross Colgate, Jessica W Crothers, Peter F Wright, Mohamed Al-Ibrahim, Erman Tritama, Annelet Vincent, Bernardo A Mainou, Yiting Zhang, Jennifer Konopka-Anstadt, Ananda S Bandyopadhyay, Alan Fix, John O Konz, Chris Gast

Open source

DOI: 10.1016/s1473-3099(25)00285-3
Published: 2025-12
Container: The Lancet Infectious Diseases
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-25-00285-3,
  title = {Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial},
  author = {Laina D Mercer and Arlene C Seña and E Ross Colgate and Jessica W Crothers and Peter F Wright and Mohamed Al-Ibrahim and Erman Tritama and Annelet Vincent and Bernardo A Mainou and Yiting Zhang and Jennifer Konopka-Anstadt and Ananda S Bandyopadhyay and Alan Fix and John O Konz and Chris Gast},
  year = {2025},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(25)00285-3},
  url = {https://doi.org/10.1016/s1473-3099(25)00285-3}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
AU  - Laina D Mercer
AU  - Arlene C Seña
AU  - E Ross Colgate
AU  - Jessica W Crothers
AU  - Peter F Wright
AU  - Mohamed Al-Ibrahim
AU  - Erman Tritama
AU  - Annelet Vincent
AU  - Bernardo A Mainou
AU  - Yiting Zhang
AU  - Jennifer Konopka-Anstadt
AU  - Ananda S Bandyopadhyay
AU  - Alan Fix
AU  - John O Konz
AU  - Chris Gast
PY  - 2025
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(25)00285-3
UR  - https://doi.org/10.1016/s1473-3099(25)00285-3
ER  -

APA

Mercer, L. D., Seña, A. C., Colgate, E. R., Crothers, J. W., Wright, P. F., Al-Ibrahim, M., Tritama, E., Vincent, A., Mainou, B. A., Zhang, Y., Konopka-Anstadt, J., Bandyopadhyay, A. S., Fix, A., Konz, J. O., & Gast, C. (2025). Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(25)00285-3

Source records

crossref · retrieved 2026-09-26T06:08:40.400Z